InsiderSignal.AI

InsiderSignal.ai

PSTV - Plus Therapeutics, Inc.

Insider Purchase by Lenk Robert P (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Lenk Robert P, serving as Dir at Plus Therapeutics, Inc. (PSTV), purchased 110,000 shares at $0.49 per share, for a total transaction value of $53,779.00. Following this transaction, Lenk Robert P now holds 139,327 shares of PSTV.

This purchase represents a 375.00% increase in Lenk Robert P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, August 25, 2025, 3 days after the trade was made.

Plus Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lenk Robert P

Lenk Robert P

Dir

Robert P. Lenk, PhD is a Director at Plus Therapeutics, Inc. (PSTV), a clinical-stage pharmaceutical company focused on targeted radiotherapeutics.[[1]](https://www.insidertrades.com/plus-therapeutics-inc-stock/robert-p-lenk/)[[2]](https://plustherapeutics.com/our-team/) He holds approximately 139,327 shares of PSTV stock, valued at over $75,000 as of late 2025, and most recently purchased 110,000 shares on August 22, 2025, at $0.49 per share.[[1]](https://www.insidertrades.com/plus-therapeutics-inc-stock/robert-p-lenk/)[[3]](https://www.gurufocus.com/insider/41958/robert-p-lenk) Dr. Lenk brings over 35 years of experience as a pharmaceutical executive, specializing in nanoparticle drug development and drug formulation.[[5]](https://www.biospace.com/plus-therapeutics-welcomes-two-new-directorsdr-robert-lenk-and-mr-howard-clowes)[[6]](https://dallas.citybuzz.co/article/601456/Comcast%20Technology%20Center%20Opens) His career highlights include serving as President and CEO of Therapeutics 2000, Inc. in 1989, which was later acquired by Coller Capital.[[4]](https://www.sec.gov/Archives/edgar/data/1095981/000156459020019787/pstv-10ka_20191231.htm) He joined the Plus Therapeutics Board as a new director, contributing his expertise to the company's leadership alongside figures like Chairman Richard Hawkins and CEO Marc Hedrick.[[2]](https://plustherapeutics.com/our-team/)

View full insider profile →

Trade Price

$0.49

Quantity

110,000

Total Value

$53,779.00

Shares Owned

139,327

Trade Date

Friday, August 22, 2025

184 days ago

SEC Filing Date

Monday, August 25, 2025

Filed 3 days after trade

HEALTHCAREBIOTECHNOLOGY

About Plus Therapeutics, Inc.

Company Overview

No company information available
View news mentioning PSTV

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/153420

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime